Reuters: Lilly pulls FDA application for Cymbalta for pain

[chris]

Lilly pulls FDA application for Cymbalta for pain
      

CHICAGO (Reuters) - Eli Lilly and Co  said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the drug's effectiveness and dosing.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login